Nanoparticles that can attack plaque — a major cause of cardiovascular disease — have been developed by UC Santa Barbara researchers.

The nanoparticles are lipid-based collections of molecules that form a sphere called a micelle that has a peptide (a piece of protein) on its surface. The peptide binds to the surface of the plaque, rupturing it.